Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer. [electronic resource]
Producer: 20180105Description: 258-264 p. digitalISSN:- 1473-1150
- Aged
- Angiogenesis Inhibitors -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- genetics
- Colectomy
- Colorectal Neoplasms -- enzymology
- Disease Progression
- Drug Resistance, Neoplasm -- genetics
- Female
- Gene Expression Profiling
- Gene Expression Regulation, Enzymologic
- Gene Expression Regulation, Neoplastic
- Genetic Predisposition to Disease
- Glycolysis -- genetics
- Hepatectomy
- Humans
- Italy
- Kaplan-Meier Estimate
- Liver Neoplasms -- enzymology
- Male
- Metastasectomy -- methods
- Mutation
- Pharmacogenetics
- Pharmacogenomic Variants
- Phenotype
- RNA, Messenger -- genetics
- Retrospective Studies
- Risk Factors
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.